Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

SEC Filings

SEC Filings

Form Description Filing date View
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1

Registration statement for face-amount certificate companies

View HTML
D View HTML
D View HTML
D View HTML
REGDEX

REGDEX

View HTML
REGDEX

REGDEX

View HTML

Copyright Morningstar



Copyright 2018 - Stemline Therapeutics, Inc. All rights reserved